PENNSYLVANIA — A couple's lawsuit against Johnson & Johnson, Janssen Research & Development LLC and Janssen Pharmaceuticals Inc. alleges breach of implied warranty, failure to warn, fraud, negligence, negligent misrepresentation and product liability.
Clint Sessions and Cynthia Sessions filed a complaint on July 13 in the U.S. District Court for the Eastern District of Pennsylvania against the defendants, alleging that they failed to provide proper warnings about taking Levaquin.
According to the complaint, the plaintiffs allege that, in May 2003, one of the plaintiffs was diagnosed with peripheral neuropathy after Levaquin was prescribed. The plaintiffs holds Johnson & Johnson; Janssen Research & Development, LLC; and Janssen Pharmaceuticals, Inc. responsible because the defendants allegedly failed to provide adequate warning on Levaquin's label regarding the potential side effects of the drug.
The plaintiffs request a trial by jury and seek general and special damages, all medical expenses, interest, a full refund of all purchase costs for FLQ drugs, compensatory damages, consequential damages, punitive damages, court costs and any further relief the court grants.
U.S. District Court for the Eastern District of Pennsylvania Case number 2:16-cv-03791-PD